Toni Choueiri M.D. Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Womens Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School Discusses mTOR & PI3 Kinase Inhibitor Study. At The Fourteenth European International Kidney Cancer Symposium on Mar 29, 2019.
mTOR & PI3 Kinase Inhibitor Study
